Ameritas Investment Partners, Inc. - AERIE PHARMACEUTICALS INC ownership

AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 179 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.6%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of AERIE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$56,000
+143.5%
3,728
+20.0%
0.00%
+200.0%
Q2 2022$23,000
-17.9%
3,1060.0%0.00%0.0%
Q1 2022$28,000
+27.3%
3,1060.0%0.00%0.0%
Q4 2021$22,000
-37.1%
3,1060.0%0.00%0.0%
Q3 2021$35,000
-30.0%
3,1060.0%0.00%
-50.0%
Q2 2021$50,000
-10.7%
3,1060.0%0.00%0.0%
Q1 2021$56,000
+14.3%
3,106
-13.9%
0.00%0.0%
Q4 2020$49,000
+16.7%
3,6060.0%0.00%0.0%
Q3 2020$42,000
-20.8%
3,6060.0%0.00%
-33.3%
Q2 2020$53,000
+8.2%
3,6060.0%0.00%0.0%
Q1 2020$49,000
-43.7%
3,6060.0%0.00%
-25.0%
Q4 2019$87,000
+26.1%
3,6060.0%0.00%
+33.3%
Q3 2019$69,000
-35.5%
3,6060.0%0.00%
-40.0%
Q2 2019$107,000
-24.1%
3,606
+21.7%
0.01%
-28.6%
Q1 2019$141,000
+31.8%
2,9640.0%0.01%
+16.7%
Q4 2018$107,000
-41.2%
2,9640.0%0.01%
-25.0%
Q3 2018$182,000
-9.0%
2,9640.0%0.01%
-20.0%
Q2 2018$200,000
+31.6%
2,964
+5.7%
0.01%
+42.9%
Q1 2018$152,000
-9.5%
2,8050.0%0.01%
-12.5%
Q4 2017$168,000
+10.5%
2,805
+5.3%
0.01%
+14.3%
Q3 2017$152,000
+8.6%
2,6650.0%0.01%0.0%
Q2 2017$140,000
+29.6%
2,665
+11.5%
0.01%
+40.0%
Q1 2017$108,0002,3900.01%
Other shareholders
AERIE PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
JACOB ASSET MANAGEMENT OF NEW YORK LLC 246,563$2,244,0001.36%
LEVIN CAPITAL STRATEGIES, L.P. 1,435,876$13,066,0001.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,695,020$42,725,0000.96%
DCF Advisers, LLC 189,565$1,725,0000.76%
DAFNA Capital Management LLC 289,040$2,630,0000.68%
RICE HALL JAMES & ASSOCIATES, LLC 1,678,609$15,275,0000.61%
Rhenman & Partners Asset Management AB 589,200$5,362,0000.53%
PFM Health Sciences, LP 1,088,566$9,906,0000.37%
NEXPOINT ASSET MANAGEMENT, L.P. 309,778$2,819,0000.36%
Granahan Investment Management 1,588,944$14,459,0000.36%
View complete list of AERIE PHARMACEUTICALS INC shareholders